Alpha Teknova (TKNO)

• Market cap: $293M
• 1 day: -5.68%
• 5 days: -6.64%
• 1 month: -18.69%
• 3 months: 5.38%
• 6 months: -31.76%
• Year to date: -34.13%
• 1 year: 218.60%
• 5 years: -78.08%
• 10 years: -78.08%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Employees: 173

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

213% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 8

36% more funds holding

Funds holding: 47 [Q4 2024] → 64 (+17) [Q1 2025]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]

0.5% less ownership

Funds ownership: 11.95% [Q4 2024] → 11.45% (-0.5%) [Q1 2025]

25% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 20

40% less capital invested

Capital invested by funds: $53.2M [Q4 2024] → $31.7M (-$21.5M) [Q1 2025]